Table 3.
Univariate | Multivariablec | |||||
---|---|---|---|---|---|---|
Mean Differenceb | 95% CI | P | Mean Difference | 95% CI | P | |
Nadir CD4 count per 100 cell/mm3 higher | 0.01 | –0.06 to 0.05 | .58 | |||
Pre-ART viral load per log10 cps/mL higher | 0.00 | –0.08 to 0.08 | .99 | |||
Duration of suppressive ART per 1 y longer | –0.01 | –0.03 to 0.00 | .12 | –0.01 | –0.02 to 0.01 | .39 |
CD4 count per 100 cells/mm3 higher | –0.01 | –0.02 to 0.02 | .92 | |||
CD4/CD8 ratio per 1 unit higher | 0.04 | –0.11 to 0.17 | .62 | |||
2-LTRc DNA per log10 cps/106 PBMC higher | 0.05 | –0.11 to 0.20 | .57 | |||
Total HIV-1 DNA per log10 cps/106 PBMC higher | –0.01 | –0.09 to 0.08 | .87 | |||
CD4+CD38+ per 50% higher | 0.08 | –0.14 to 0.30 | .47 | |||
CD4+CD26+ per 50% higher | 0.08 | –0.10 to 0.27 | .37 | |||
CD4+CD69+ per 50% higher | –0.61 | –2.97 to 1.75 | .60 | |||
CD8 count per 100 cells/mm3 higher | 0.02 | –0.01 to 0.01 | .70 | |||
CD8+CD38+ per 50% higher | 0.32 | –0.11 to 0.75 | .16 | 0.26 | –0.17 to 0.68 | .24 |
CD8+HLA-DR/DP/DQ+ per 50% higher | –0.03 | –0.21 to 0.15 | .76 | |||
sCD14 per log10 µg /mL higher | 0.26 | –0.24 to 0.75 | .31 | |||
sCD27 per log10 U/mL higher | 0.49 | 0.17 to 0.81 | .003 | 0.37 | 0.01 to 0.73 | .02 |
sCD30 per log10 ng/mL higher | 0.21 | –0.02 to 0.45 | .07 | 0.02 | –0.25 to 0.28 | .88 |
IL6 per log10 pg/mL higher | 0.13 | –0.05 to 0.30 | .15 | 0.12 | –0.06 to 0.29 | .19 |
Abbreviations: 2-LTRc DNA, 2-LTR circular HIV-1 DNA; ART, antiretroviral therapy; CI, confidence interval; cps, copies; PBMC, peripheral blood mononuclear cell.
aThe analysis excluded the 2 outliers with residual plasma HIV-1 RNA >11 copies/mL.
bMean difference in log10 copies/mL.
cVariables with P < .2 in the univariable analysis were included in the multivariable analysis.